Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today

Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today

Source: 
Motley Fool
snippet: 

One pundit feels there is solid potential in one of the company's more recently approved drugs.